Cardiomegaly medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; '''Associate Editor in Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor in Chief:''' {{CZ}} | ||
==Medical Therapy== | ==Medical Therapy== | ||
=== Acute Pharmacotherapies === | === Acute Pharmacotherapies === | ||
| Line 15: | Line 15: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Disease]] | |||
[[Category:Needs overview]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 16:32, 3 January 2013
|
Cardiomegaly Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiomegaly medical therapy On the Web |
|
Directions to Hospitals Treating Cardiomegaly medical therapy |
|
Risk calculators and risk factors for Cardiomegaly medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]
Medical Therapy
Acute Pharmacotherapies
Administration of digoxin, diuretics, antiarrhythmics and/or preload and afterload reducers per clinical indication
Chronic Pharmacotherapies
A combination of diuretics and angiotensin converting enzyme (ACE) inhibition is currently the standard of care. Digoxin may reduce the frequency of rehospitalization, but does not improve mortality.